PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )This micro-blog is specifically for a discussion of equities trading in Pre-Market or After-Market, Or Extremely URGENT, verifiable News relating to Global Markets.
It may also include certain nuances in specific markets and sharing of information with others on their Standard Operating Procedures, as well as access to those markets.
Have FUN, keep it real and enjoy each others company, tidbits of advice, humor, expertise or lack thereof. The Gummunity is a Sharing and Caring environment; Please Keep It Clean.
Bes2ALL! – >>>–BenJammmin’——->
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Share your thoughts...
179 Comments on "
PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )"
$TEUM fp > Pareteum and Artilium Announce Agreement for Pareteum to Acquire Artilium in $104.7 Million Transaction https://www.pareteum.com/news/pareteum-and-artilium-announce-agreement-for-pareteum-to-acquire-artilium-in-104-7-million-transaction/
Pareteum and Artilium Announce Agreement for Pareteum to Acquire Artilium in $104.7 Million Transaction
Pro-Forma 2018 Revenue Outlook of $49 Million
Expected to be Accretive to 2019 Earnings
Conference Call Scheduled for Friday, June 8 at 11am ET
🙂 #Best2ALL! 🙂
$TSLA Short sellers betting against Tesla lose more than $1 billion in single day as stock pops https://cnb.cx/2Lqk36O #tesla #tsla #stockstowatch #investing #trading #WallStreet #markets
#Thanks @TipRanks https://twitter.com/TipRanks/status/1004614289414553600
$MDGL priced 1.34M shares at $305/Share
Thx Odi https://twitter.com/odibro/status/1004652269411979264
$FSLR $CSIQ $JKS $SPWR $SOL Billions in U.S. solar projects shelved after Trump panel tariff https://twitter.com/ACInvestorBlog/status/1004595565257256960
$TEVA $CMRE $SRRA $AETI $GALT and more. Watchlist: https://finviz.com/screener.ashx?v=211&ta=0&t=TEVA,ATNM,DARE,AETI,CMRE,EGY,HEAR,VSAR,CHK,GALT,IQ,SRRA ,CHRS,WRD,ENPH,STG … Thx BMT https://twitter.com/BioMoneyTrees/status/1004933313809838080 hear srra wow Best
$BLPH wow Form 4 x8 directors 38,216 options each @ 2.27usd Best
$BLPH WOW! > +1/4 to long position at $248 Data due June or July.
🙂 #Best2ALL! 🙂
$CLRB wow > Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131 https://globenewswire.com/news-release/2018/06/07/1518403/0/en/Cellectar-Granted-U-S-Patent-for-the-Treatment-of-Various-Cancers-and-Cancer-Stem-Cells-with-CLR-131.html
$CLRB FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma https://globenewswire.com/news-release/2018/06/06/1517601/0/en/FDA-Grants-Rare-Pediatric-Disease-Designation-to-Cellectar-Biosciences-CLR-131-for-the-Treatment-of-Rhabdomyosarcoma.html
$TEUM WOW! > +3X at 2.24 Conference call Q&A currently either on website or toll free call. Travis, have you assessed THIS equity and transaction? 🙂 #Best2ALL! 🙂
$AXSM long at $3.20 🙂 Best 🙂
$AXSM Form 4 6/19 http://archive.fast-edgar.com//20180620/A7AZC22C8Z22O2Z222942MZZGVTPZ2Y2DVA2/ Best
$CLRB ow > Cellectar Reports 94% Reduction in Overall Tumor Volume in Waldenstrom Macroglobulinemia Patient in Phase 2 CLR 131 Clinical Study http://investor.cellectarbiosciences.com/news-releases/news-release-details/cellectar-reports-94-reduction-overall-tumor-volume-waldenstrom 🙂 Best2ALL! 🙂
$APTO ow > Insider Filing Browser https://ceo.ca/api/sedi/?symbol=APS&amount=&transaction=&insider= … #Best2You!
$MBRX Moleculin Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia https://ir.moleculin.com/press-releases/detail/94 Best
$CLRB > July 18, 2018 8:00 AM EDT
Cellectar Reports Positive Phase 2 Interim Data for CLR 131 in Relapsed/Refractory DLBCL Patients
http://investor.cellectarbiosciences.com/news-releases/news-release-details/cellectar-reports-positive-phase-2-interim-data-clr-131
$CLRB – So, Gr8Full! – Here’s a question: why on the 17th at opening did $CLRB virtually double its price to $11.24 and then slowly deflate all during the day? Single large purchase or ? Just curious …
$CLRB long > I was not watching the tape at the time, Allison. There are several minutes on the 1 minute chart with volume exceeding 150K. #Best2YouAlwayz!
$CLRB, didn’t they just do a reverse split? Best to all….John
$CLRB > Cellectar Reports Positive Phase 2 Interim Data for CLR 131 in Relapsed/Refractory DLBCL Patients http://investor.cellectarbiosciences.com/news-releases/news-release-details/cellectar-reports-positive-phase-2-interim-data-clr-131
$CLRB > Corporate Presentation Jul 2018 http://investor.cellectarbiosciences.com/node/11676/html #Best2You!
$RKDA up 30% at $9.00 in #premarket. Arcadia Biosciences, Shriram Bioseed reach milestone in developing extended shelf life tomatoes. https://twitter.com/Super1NYC/status/1019892455272050689
$KALTF >
Kalytera to Enter Medical Cannabis Market With Focus on Treatment of Psoriasis and Menstrual Cramps
Website Home: https://kalytera.co/
News and Insights: https://kalytera.co/news/ 🙂 Best2YOU! 🙂
$BIOC > Biocept Reminds Investors of Today’s Deadline to be a Shareholder of Record
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors https://ir.archtherapeutics.com/press-releases/detail/510
TGIF #Best2YOU!
$KALTF > Kalytera and Former Shareholders of Talent Biotechs Agree to Deferment of Milestone Payments Website Home: https://kalytera.co/
News and Insights: https://kalytera.co/news/ Best
$AKAO > Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI) http://investors.achaogen.com/news-releases/news-release-details/achaogen-launches-zemdritm-plazomicin-once-daily-aminoglycoside Best
$AKAO > Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI) http://investors.achaogen.com/news-releases/news-release-details/achaogen-launches-zemdritm-plazomicin-once-daily-aminoglycoside Best
# BEN, always GR8 to read your posts and the wealth of info you share. has been awhile since i even been on a computer, so just started again. Currently long $AUPH, $TRXC, $SGMO and just took a started position with $CVRS. As for $AUPH hopefully some movement by year end with their DES. $TRXC , in june they submitted another 510 for more instruments and more sales looming. Thanks again Ben for your info, will be back more now that the wife is somewhat better…best to all….John
$CLRB ow > Hi John. It’s great to hear from you!
Glad to hear that your wife is better.
Yes $CLRB completed their 1:10 reverse split.
Still wow $AUPH; looking forward to read outs. I am unable to invest in $TRXC because of past history; choose to avoid; too many other great companies with ethics. You’ve piqued my interest with $CVRS; shall DD.
Looking forward to hearing from you often. 🙂 #Best2You! 🙂
$CRVS > Corindus Announces Significant Progress in the Development of Remote Vascular Robotic Technology with the CorPath GRX® System https://investors.corindus.com/investors/news-and-events/press-releases/press-release-details/2018/Corindus-Announces-Significant-Progress-in-the-Development-of-Remote-Vascular-Robotic-Technology-with-the-CorPath-GRX-System/default.aspx #Best2ALL!
$CWBR Wow relevant > Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model, by turning off the gene responsible for mitochondrial dysfunction that drives age-related diseases. https://www.nature.com/articles/s41419-018-0765-9 …
ty https://twitter.com/ajitjohnson_n/status/1020931727772901376
$CWBR relevant > The Most Important Asset
Posted July 17, 2018 by Nick Maggiulli
Rethinking How To View Your Time via Ian Cassel, Thank you!
https://ofdollarsanddata.com/the-most-important-asset/
Truth is a deep kindness that teaches us to be content in our everyday life and share with the people the same happiness. ~ Khalil Gibran
Thanks for reminding me. Excellent article
$LEAP ow > Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors http://investors.leaptx.com/phoenix.zhtml?c=254460&p=irol-newsArticle&ID=2359396 Have an awesome week and beyond. Best
$LPTX July presentation (Thank you OneMD ) https://www.leaptx.com/file.cfm/1/docs/Leap%20Non-Con%20July%202018%20Update.pdf Best
$APRO ow > Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018 http://globenewswire.com/news-release/2018/07/24/1541102/0/en/Aptose-To-Release-Second-Quarter-Ended-June-30-2018-Financial-Results-and-Hold-Conference-Call-on-August-7-2018.html Best
$MYSZ > Go Ecommerce Tel-Aviv https://ir.mysizeid.com/press-releases/
DATE: 25th July 2018
Go eCommerce 6 will be held under the main theme “What’s your e factor?” and will showcase companies’ fascinating success stories and discuss the many challenges on the way to success.
This is the biggest eCommerce event in Israel for the sixth year, and MySize is not going to miss it!
Come meet us at the Go eCommerce 2018, in David Intercontinental Hotel, 12 Kaufman St. Tel Aviv #Best2ALL!
$MYSZ > Go Ecommerce Tel-Aviv https://ir.mysizeid.com/press-releases/
DATE: 25th July 2018
Go eCommerce 6 will be held under the main theme “What’s your e factor?” and will showcase companies’ fascinating success stories and discuss the many challenges on the way to success.
This is the biggest eCommerce event in Israel for the sixth year, and MySize is not going to miss it!
Come meet us at the Go eCommerce 2018, in David Intercontinental Hotel, 12 Kaufman St. Tel Aviv #Best2ALL!